General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)
NCT04773314
·
clinicaltrials.gov ↗
COMPLETED
Status
409
Enrollment
INDUSTRY
Sponsor class
Conditions
Cervical Ripening
Pregnancy
Interventions
OTHER:
PROPESS Cohort
Sponsor
Ferring Pharmaceuticals